Who owns Xenon Pharmaceuticals?
- Ticker: XENE
- CUSIP Number: 98420n105
Tip: Access positions for across all investors
Analyze quarterly positions in Xenon Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xenon Pharmaceuticals stock
Who bought or sold Xenon Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 8.9M | $400M | 0% | Dec 2025 |
|
| BlackRock | 5.6M | $328M | 11% | Mar 2026 |
|
| venBio Select Advisor | 5.4M | $243M | 0% | Dec 2025 |
|
| Wellington Management Company | 4.8M | $214M | 32% | Dec 2025 |
|
| Driehaus Capital Management | 4.5M | $203M | 9% | Dec 2025 |
|
| Henderson Group | 4.2M | $243M | 6% | Mar 2026 |
|
| Citadel Advisors | 2.9M | $168M | 102% | Mar 2026 |
|
| Capital Research and Management Company - Division 3 | 2.7M | $156M | -22% | Mar 2026 |
|
| Polar Capital Holdings | 2.5M | $111M | -3% | Dec 2025 |
|
| Deerfield Management Company | 1.6M | $94M | 198% | Mar 2026 |
|
| Holocene Advisors | 1.5M | $88M | 18% | Mar 2026 |
|
| State Street Corporation | 1.5M | $67M | 2% | Dec 2025 |
|
| Alliancebernstein | 1.4M | $63M | -12% | Mar 2026 |
|
| Westfield Capital Management Company | 1.4M | $82M | 14% | Mar 2026 |
|
| Braidwell | 1.3M | $78M | -27% | Mar 2026 |
|
| Jennison Associates | 1.3M | $77M | 2% | Mar 2026 |
|
| Alyeska Investment Group | 1.3M | $76M | 100% | Mar 2026 |
|
| Franklin Resources | 1.3M | $75M | 69% | Mar 2026 |
|
| Affinity Asset Advisors | 1.3M | $56M | -11% | Dec 2025 |
|
| Caligan Partners | 1.1M | $49M | 147% | Dec 2025 |
|
| Geode Capital Management | 1.1M | $64M | 15% | Mar 2026 |
|
| Bnp Paribas Investment Partners | 1.1M | $47M | 58% | Dec 2025 |
|
| OrbiMed Advisors | 1.1M | $62M | 137% | Mar 2026 |
|
| Federated Investors | 972k | $57M | 45% | Mar 2026 |
|
| Capital World Investors | 840k | $49M | 28% | Mar 2026 |
|
| Commodore Capital | 825k | $48M | -54% | Mar 2026 |
|
| Siren | 813k | $36M | 0% | Dec 2025 |
|
| First Turn Management | 800k | $36M | 0% | Dec 2025 |
|
| Goldman Sachs Group | 770k | $45M | 11% | Mar 2026 |
|
| Rock Springs Capital Management | 763k | $44M | -3% | Mar 2026 |
|
| Fiera Capital Corporation | 710k | $41M | 3% | Mar 2026 |
|
| Adage Capital Partners GP | 685k | $31M | -18% | Dec 2025 |
|
| American Century Companies | 681k | $31M | 3% | Dec 2025 |
|
| Pictet Asset Management Holding SA | 680k | $39M | 9% | Mar 2026 |
|
| Vanguard Group | 665k | $30M | -22% | Dec 2025 |
|
| Trails Edge Capital Partners | 640k | $37M | 100% | Mar 2026 |
|
| Vestal Point Capital | 640k | $37M | 7% | Mar 2026 |
|
| Loomis, Sayles and | 612k | $27M | -4% | Dec 2025 |
|
| Standard Life Aberdeen | 610k | $36M | -19% | Mar 2026 |
|
| Two Sigma Investments | 606k | $35M | 39% | Mar 2026 |
|
| Barclays | 601k | $27M | 440% | Dec 2025 |
|
| MPM Oncology Impact Management | 589k | $34M | 21% | Mar 2026 |
|
| Caption Management | 580k | $26M | 262% | Dec 2025 |
|
| T. Rowe Price Investment Management | 548k | $25M | -9% | Dec 2025 |
|
| Vanguard Portfolio Management | 543k | $32M | 100% | Mar 2026 |
|
| Tudor Investment Corporation | 543k | $32M | 108% | Mar 2026 |
|
| Octagon Capital Advisors | 490k | $29M | 100% | Mar 2026 |
|
| Novo A/S | 485k | $28M | 100% | Mar 2026 |
|
| Candriam Luxembourg S.C.A. | 477k | $28M | 14% | Mar 2026 |
|
| Morgan Stanley | 474k | $45M | 61% | Mar 2026 |
|
| Logos Global Management | 450k | $26M | 100% | Mar 2026 |
|
| Northern Trust | 439k | $20M | -12% | Dec 2025 |
|
| Bank of New York Mellon | 396k | $23M | 2% | Mar 2026 |
|
| Ubs Global Asset Management Americas | 375k | $22M | 158869% | Mar 2026 |
|
| Baker Bros. Advisors | 370k | $22M | 0% | Mar 2026 |
|
| TimesSquare Capital Management | 359k | $21M | -33% | Mar 2026 |
|
| Jane Street | 349k | $20M | 1297% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 325k | $19M | 100% | Mar 2026 |
|
| Sofinnova Ventures | 305k | $18M | 410% | Mar 2026 |
|
| Soleus Capital Management | 292k | $17M | 100% | Mar 2026 |
|
| Boothbay Fund Management | 270k | $16M | 279% | Mar 2026 |
|
| Bank of America Corporation | 265k | $15M | 100% | Mar 2026 |
|
| Algert Coldiron Investors | 264k | $15M | 114% | Mar 2026 |
|
| Redmile Group | 263k | $15M | 96% | Mar 2026 |
|
| DAFNA Capital Management | 251k | $15M | -13% | Mar 2026 |
|
| Nuveen | 250k | $15M | 16% | Mar 2026 |
|
| Nan Fung Trinity | 248k | $14M | 9% | Mar 2026 |
|
| Allspring Global Investments Holdings | 246k | $14M | 100% | Mar 2026 |
|
| Nicholas Investments Partners | 243k | $11M | 104% | Dec 2025 |
|
| Duquesne Family Office | 239k | $14M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 234k | $14M | 177% | Mar 2026 |
|
| Iron Triangle Partners | 234k | $11M | 100% | Dec 2025 |
|
| Eversept Partners | 231k | $10M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 229k | $13M | 12% | Mar 2026 |
|
| LMR Partners | 228k | $13M | 46% | Mar 2026 |
|
| Patient Square Capital | 227k | $13M | 66% | Mar 2026 |
|
| State of Wisconsin Investment Board | 206k | $9.2M | -1% | Dec 2025 |
|
| Millennium Management | 202k | $12M | -68% | Mar 2026 |
|
| Charles Schwab Investment Management | 189k | $8.5M | 0% | Dec 2025 |
|
| New York State Common Retirement Fund | 189k | $11M | 1% | Mar 2026 |
|
| DnB NOR Asset Management AS | 181k | $11M | -34% | Mar 2026 |
|
| Neuberger Berman Group | 179k | $8.0M | 4% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 163k | $9.5M | -14% | Mar 2026 |
|
| Marshall Wace | 163k | $7.3M | -73% | Dec 2025 |
|
| Foresite Capital Management IV | 160k | $9.3M | 0% | Mar 2026 |
|
| Swiss National Bank | 158k | $9.2M | 38% | Mar 2026 |
|
| Parkman Healthcare Partners | 154k | $6.9M | -12% | Dec 2025 |
|
| Woodline Partners | 150k | $8.7M | 100% | Mar 2026 |
|
| Peregrine Capital Management | 143k | $8.3M | -18% | Mar 2026 |
|
| Stempoint Capital | 141k | $8.2M | -60% | Mar 2026 |
|
| Susquehanna International | 137k | $6.1M | -16% | Dec 2025 |
|
| Russell Investments | 129k | $7.5M | 50% | Mar 2026 |
|
| KBC Group NV | 129k | $7.5M | 4541% | Mar 2026 |
|
| Sphera Funds Management | 127k | $7.4M | 100% | Mar 2026 |
|
| Hsbc Holdings | 122k | $7.1M | 100% | Mar 2026 |
|
| Wells Fargo & Company | 116k | $6.7M | -24% | Mar 2026 |
|
| Mutual Of America Capital Management | 116k | $6.7M | 0% | Mar 2026 |
|
| Sei Investments | 114k | $6.7M | 161% | Mar 2026 |
|
| Rhumbline Advisers | 102k | $5.9M | 13% | Mar 2026 |
|
| Burkehill Global Management | 100k | $5.8M | 100% | Mar 2026 |
|
| UBS Group | 100k | $5.8M | 90% | Mar 2026 |
|
| Axiom International Investors | 100k | $5.8M | 100% | Mar 2026 |
|
| Verition Fund Management | 94k | $4.2M | 64% | Dec 2025 |
|
| Granahan Investment Management | 93k | $4.2M | 6% | Dec 2025 |
|
| California State Teachers Retirement System | 93k | $5.4M | 64% | Mar 2026 |
|
| Royal Bank of Canada | 90k | $4.9M | -25% | Mar 2026 |
|
| Y-Intercept | 85k | $5.0M | 17% | Mar 2026 |
|
| Raymond James Financial | 83k | $3.7M | 19% | Dec 2025 |
|
| Schroder Investment Management Group | 81k | $3.6M | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 80k | $4.7M | -14% | Mar 2026 |
|
| Aquatic Capital Management | 79k | $4.6M | 100% | Mar 2026 |
|
| Ameriprise Financial | 79k | $4.6M | -28% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 75k | $4.4M | 100% | Mar 2026 |
|
| Seven Grand Managers | 75k | $4.4M | 100% | Mar 2026 |
|
| Nomura Holdings | 75k | $4.4M | -50% | Mar 2026 |
|
| Vanguard Asset Management | 75k | $4.3M | 100% | Mar 2026 |
|
| Legal & General Group | 74k | $4.3M | 5% | Mar 2026 |
|
| Ing Investment Management | 68k | $4.0M | 12% | Mar 2026 |
|
| ALPS Advisors | 68k | $3.9M | 7% | Mar 2026 |
|
| Trexquant Investment | 67k | $3.9M | 100% | Mar 2026 |
|
| Eudaimonia Asset Management | 67k | $3.9M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 66k | $3.8M | 100% | Mar 2026 |
|
| Artia Global Partners | 65k | $3.8M | 62% | Mar 2026 |
|
| CastleArk Management | 65k | $3.8M | 100% | Mar 2026 |
|
| Atika Capital Management | 60k | $3.5M | -35% | Mar 2026 |
|
| Invesco | 59k | $3.4M | 16% | Mar 2026 |
|
| Quantinno Capital Management | 55k | $3.2M | 125% | Mar 2026 |
|
| Palo Alto Investors | 51k | $3.0M | -47% | Mar 2026 |
|
| Lazard Asset Management | 51k | $3.0M | -35% | Mar 2026 |
|
| Erste Asset Management GmbH | 50k | $2.8M | 0% | Mar 2026 |
|
| Nomura Asset Management International | 47k | $2.7M | 100% | Mar 2026 |
|
| MetLife Investment Advisors | 42k | $1.9M | -5% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 41k | $2.4M | 15% | Mar 2026 |
|
| DekaBank Deutsche Girozentrale | 39k | $2.2M | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 39k | $2.3M | 26% | Mar 2026 |
|
| Legato Capital Management | 37k | $2.1M | -1% | Mar 2026 |
|
| Envestnet Asset Management | 36k | $2.1M | 1% | Mar 2026 |
|
| Zurcher Kantonalbank | 35k | $2.0M | 38% | Mar 2026 |
|
| ACT Capital Management | 34k | $1.9M | 100% | Mar 2026 |
|
| Jump Financial | 31k | $1.4M | 377% | Dec 2025 |
|
| TLS Advisors | 31k | $1.8M | 64% | Mar 2026 |
|
| Calamos Advisors | 30k | $1.8M | 100% | Mar 2026 |
|
| Creative Planning | 30k | $1.7M | 55% | Mar 2026 |
|
| Handelsbanken Fonder AB | 30k | $1.7M | 0% | Mar 2026 |
|
| CI Private Wealth | 28k | $1.6M | 13% | Mar 2026 |
|
| Rhenman & Partners Asset Management AB | 28k | $1.6M | -80% | Mar 2026 |
|
| TD Asset Management | 27k | $1.6M | -29% | Mar 2026 |
|
| Swedbank AB | 26k | $1.5M | 100% | Mar 2026 |
|
| SummitTX Capital | 26k | $1.5M | 100% | Mar 2026 |
|
| Bamco | 25k | $1.5M | -17% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 22k | $1.3M | -34% | Mar 2026 |
|
| Neo Ivy Capital Management | 7.5k | $335k | -85% | Dec 2025 |
|
Who sold out of Xenon Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2025 | 1.4M | $56M |
| Saturn V Capital Management | Sep 2025 | 504k | $20M |
| Dimensional Fund Advisors | Dec 2025 | 452k | $20M |
| Deep Track Capital | Dec 2025 | 366k | $16M |
| Two Sigma Advisers | Dec 2025 | 259k | $12M |
| Perceptive Advisors | Dec 2025 | 201k | $9.0M |
| Jain Global | Dec 2025 | 174k | $7.8M |
| Moore Capital Management | Dec 2025 | 140k | $6.3M |
| Assenagon Asset Management | Dec 2025 | 119k | $5.3M |
| Man Group | Dec 2025 | 115k | $5.1M |
| HighVista Strategies | Sep 2025 | 82k | $3.3M |
| Dark Forest Capital Management | Dec 2025 | 34k | $1.5M |